Proton pump inhibitors (PPIs) are a class of very effective and generally safe medicines used to treat heartburn, gastroesophageal reflux disease (GERD), and gastric ulcers.But not everyone who ...

Proton pump inhibitors (PPIs) are widely used for the treatment of gastroesophageal reflux disease as well as other acid-related disorders. PPIs are metabolized primarily via the CYP2C19 and ...

Proton-pump inhibitors (PPIs) are frequently prescribed to suppress stomach acid in patients with gastroesophageal reflux ...

Although not specifically approved for the treatment of bleeding peptic ulcers, proton pump inhibitors (PPIs) such as omeprazole (Losec AstraZeneca, Luton, UK) are widely used for this indication.

Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a ...

Objective To determine whether proton pump inhibitors (PPIs) are associated with an increased risk of colorectal cancer, compared with histamine-2 receptor antagonists (H2RAs). Design The United ...

Proton pump inhibitors (PPI) use is associated with increased risk of enteric infections, in particular with a 65% increase in incidence of Clostridium difficile infection. PPI is one of the most ...

Voquezna works faster and lasts longer than proton pump inhibitors, the most common drug treatment for GERD. In addition to ...

After a landmark $US425 million settlement in the United States, the drugs are being investigated in Australia over alleged ...

The following is a summary of “Gastrointestinal dysmotility is associated with proton pump inhibitor refractory esophagitis in patients with systemic sclerosis,” published in the September 2024 issue ...

[44] Proton pump inhibitors are well-tolerated drugs. There is no clear evidence of increased toxicity among poor metabolizers, despite a markedly elevated AUC. [22] The risk of minor adverse ...